Most Recent Links
Follow us on Facebook or subscribe to our mailing list, to receive news updates. Learn more.
Dan Garisto If you’ve ever felt the urge to tap along to music, this research may strike a chord. Recognizing rhythms doesn’t involve just parts of the brain that process sound — it also relies on a brain region involved with movement, researchers report online January 18 in the Journal of Cognitive Neuroscience. When an area of the brain that plans movement was disabled temporarily, people struggled to detect changes in rhythms. The study is the first to connect humans’ ability to detect rhythms to the posterior parietal cortex, a brain region associated with planning body movements as well as higher-level functions such as paying attention and perceiving three dimensions. “When you’re listening to a rhythm, you’re making predictions about how long the time interval is between the beats and where those sounds will fall,” says coauthor Jessica Ross, a neuroscience graduate student at the University of California, Merced. These predictions are part of a system scientists call relative timing, which helps the brain process repetitive sounds, like a musical rhythm. “Music is basically sounds that have a structure in time,” says Sundeep Teki, a neuroscientist at the University of Oxford who was not involved with the study. Studies like this, which investigate where relative timing takes place in the brain, could be crucial to understanding how the brain deciphers music, he says. |© Society for Science & the Public 2000 - 2018.
Keyword: Hearing
Link ID: 24675 - Posted: 02.17.2018
By John Carroll, For years now the gold standard for R&D in Alzheimer’s disease has focused on generating convincing evidence that any new therapy being studied could slow the cognitive decline of patients and help preserve their ability to perform the kind of daily functions that can keep a patient independent for a longer period of time. That’s a hurdle no one has managed to clear for well over a decade. So now, with late-stage clinical failures piling up, the U.S. Food and Drug Administration (FDA) has set off down a path to adapt those standards as researchers are pushed inexorably into earlier and earlier forms of the disease, ahead of the brain damage inflicted by Alzheimer’s. In a set of draft guidances, the agency essentially proposed to offer an approval pathway for new drugs that could prevent the onset of the devastating symptoms of Alzheimer’s if drug developers could hit acceptable biomarkers that indicate the drug is working. And they’re likely going to continue with a new gold standard that will focus on long-term cognition alone, lowering the bar for drugs for an enormous and growing market. David Miller, the clinical vice president of Bracket, a Washington, D.C.-based tech provider which specializes in Alzheimer’s studies, tells me the draft guidance hit just after a meeting of the Washington, D.C.-based Alzheimer’s Association research group, which was discussing how you might be able to use a mix of markers for amyloid β and tau—two toxic proteins frequently cited as likely triggers—alongside neurodegenerative markers to identify patients who could be enrolled at a very early point in the disease. © 2018 American Association for the Advancement of Science.
Keyword: Alzheimers
Link ID: 24674 - Posted: 02.17.2018
Nicola Davis Pilot studies have shown that changes in vesicles in men’s semen mirror that in their sperm, suggesting that, as in mice, the two interact. Pilot studies have shown that changes in vesicles in men’s semen mirror that in their sperm, suggesting that, as in mice, the two interact. Photograph: Alamy Stressed fathers may end up with changes to their sperm that could affect behaviour in their offspring, research in mice has shown. Previous work by the team found that male mice who were exposed to a mildly stressful event, such as being restrained, produced sperm that was richer in certain types of molecules called microRNAs. Crucially, the higher levels of these microRNAs in the sperm seemed to result in offspring with a dampened response to stress. That, scientists have noted, could affect the mental health of offspring, since an inability to respond appropriately to stress has been linked to neuropsychiatric disorders such as PTSD and depression. “The hypothalamus, the part of the brain that determines your stress response, has been wired differently,” said Tracy Bale, professor of neuroscience at the University of Maryland School of Medicine, who is presenting the new research at the meeting of the American Association for the Advancement of Science in Austin, Texas. Now the researchers say they have unpicked what is going on through work in both mice and cultured cells – experiments known as “stress in the dish”.
Keyword: Stress; Epigenetics
Link ID: 24673 - Posted: 02.17.2018
By Roni Dengler AUSTIN—Babies are as primed to learn a visual language as they are a spoken one. That’s the conclusion of research presented here today at the annual meeting of AAAS, which publishes Science. Parents and scientists know babies are learning sponges that can pick up any language they’re born into. But not as much is known about whether that includes visual language. To find out if infants are sensitive to visual language, Rain Bosworth, a psychologist at the University of California, San Diego, tracked 6-month-olds’ and 1-year-olds’ eye movements as they watched a video of a woman performing self-grooming gestures, such as tucking her hair behind her ear, and signing. The infants watched the signs 20% more than the 1-year-old children did. That means babies can distinguish between what’s language and what’s not, even when it’s not spoken, but 1-year-olds can’t. That’s consistent with what researchers know about how babies learn spoken language. Six-month-olds home in on their native language and lose sensitivity to languages they’re not exposed to, but by 12 months old that’s more or less gone, Bosworth says. The researchers also watched babies’ gazes as they observed a signer “fingerspelling,” spelling out words with individually signed letters. The signer executed the fingerspelling cleanly or sloppily. Again, researchers found the 6-month-old babies, who had never seen sign language before, favored the well-formed letters, whereas the 12-month-olds did not show a preference. Together that means there’s a critical developmental window for picking up even nonverbal languages. As 95% of deaf children are born to hearing parents, they are at risk for developmental delays because they need that language exposure early on, the scientists say. © 2018 American Association for the Advancement of Science
Keyword: Language; Development of the Brain
Link ID: 24672 - Posted: 02.17.2018
By GINA KOLATA A group of American diplomats stationed in Havana appear to have symptoms of concussion without ever having received blows to their heads, medical experts have found. The diplomats originally were said to have been victims of a “sonic attack,” a possibility that the Federal Bureau of Investigation reportedly ruled out in January. The experts’ report, published late Wednesday in the journal JAMA, does not solve the mystery, instead raising even more questions about what could have caused the brain injuries. The incidents occurred in 2016, when 18 of the 21 affected diplomats reported they heard strange sounds in their homes or hotel rooms. The noises were loud and sounded like buzzing or grinding metal, or piercing squeals or humming, the diplomats recalled. Many said they felt increased air pressure, as if they were riding in a car with the windows rolled partway down. Three diplomats said they felt a vibration. All but one reported immediate symptoms: headache, pain in one ear, loss of hearing. Days or weeks later, other symptoms emerged, including memory problems, an inability to concentrate, mood problems, headaches and fatigue. The State Department asked researchers at the University of Pennsylvania to investigate. Their report confirmed neurological problems in the diplomats, including signs of what appear to be concussions. “The study was conducted by the top concussion research team in the world utilizing state-of-the-art methods,” said C. Edward Dixon, a professor of neurological surgery at the University of Pittsburgh, who was not involved in the research. The findings suggest “a significant brain insult,” he said. © 2018 The New York Times Company
Keyword: Brain Injury/Concussion
Link ID: 24671 - Posted: 02.16.2018
By Richard Stone U.S. diplomats who fell ill in Cuba are victims of a new neurological syndrome, according to brain researchers at the University of Pennsylvania. But the team was unable to shed light on the malady’s mysterious cause, which the U.S. State Department has characterized as a “health attack.” From late 2016 through August 2017, as many as 24 U.S. citizens affiliated with the U.S. Embassy in Havana reported symptoms ranging from vertigo and sleeplessness to cognitive impairment. Many described hearing loud or disconcerting sounds before the onset of symptoms, or pressure sensations in their ears akin to the baffling that occurs in a moving car with the windows cracked open. “They felt something weird going on,” and when they moved away from the perceived exposure, some of “the symptoms abated,” says Douglas Smith, director of Penn’s Center for Brain Injury and Repair. The State Department called in the Penn group after initial examinations of diplomats at the University of Miami in Florida revealed persistent and inexplicable symptoms. The Penn team’s report on the diplomats’ health appears in today’s issue of The Journal of the American Medical Association (JAMA). The coincidence of the diplomats’ impairment and the auditory phenomena fueled speculation they were victims of a “sonic attack.” Last summer, citing what it saw as Cuba’s inability to protect U.S. diplomats, the State Department pulled most of its personnel out of Cuba and expelled from the U.S. a corresponding number of Cuban diplomats. The Cuban government has denied knowledge of an attack and has cooperated with the U.S. investigation, which is being spearheaded by the FBI. © 2018 American Association for the Advancement of Science
Keyword: Brain Injury/Concussion
Link ID: 24670 - Posted: 02.16.2018
A small group of cells in the brain can have a big effect on seizures and memory in a mouse model of epilepsy. According to a new study in Science, loss of mossy cells may contribute to convulsive seizures in temporal lobe epilepsy (TLE) as well as memory problems often experienced by people with the disease. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. “The role of mossy cells in epilepsy has been debated for decades. This study reveals how critical these cells are in the disease, and the findings suggest that preventing loss of mossy cells or finding ways to activate them may be potential therapeutic targets,” said Vicky Whittemore, Ph.D., program director at NINDS. Mossy cells, named for the dense moss-like protrusions that cover their surface, are located in the hippocampus, a brain area that is known to play key roles in memory. Loss of mossy cells is associated with TLE, but it is unknown what role that plays in the disease. Using state-of-the-art tools, Ivan Soltesz, Ph.D., professor of neurosurgery and neurosciences at Stanford University, Palo Alto, California, and his team were able to turn mossy cells on and off to track their effects in a mouse model of epilepsy. “This study would not have been possible without the rapid advancement of technology, thanks in part to the BRAIN Initiative, which has encouraged scientists to develop innovative instruments and new ways to look at the brain,” said Dr. Soltesz. “It’s remarkable that we can manipulate specific brain cells in the hippocampus of a mouse. Using 21st century tools brings us closer than ever to unlocking the mysteries behind this debilitating disease.”
Keyword: Epilepsy; Learning & Memory
Link ID: 24669 - Posted: 02.16.2018
Blood-thinning drugs may increase rather than cut the risk of stroke in some people over 65 who have an irregular heartbeat and also chronic kidney disease, according to a new study. The researchers are calling on doctors to be more cautious in prescribing the drugs, called anticoagulants, until there has been more research. Research led by scientists at University College London highlights the problems with polypharmacy – the use of multiple drugs for people with more than one health issue. Older people are especially likely to be on medication for more than one complaint. The researchers enrolled nearly 7,000 patients who had chronic kidney disease and were then diagnosed with atrial fibrillation – the most common form of irregular heartbeat. It affects at least 33.5 million people over the age of 55 worldwide and accounts for 1% of the NHS health budget in the UK. Chronic kidney disease is also common, says the paper in the British Medical Journal, affecting 10-15% of adults. A third also have atrial fibrillation. About half a million people in the UK have both conditions and could be prescribed blood-thinning drugs. The researchers monitored the participants, half of whom were on blood-thinning drugs and half not, for 506 days. They found those on the medication were 2.6 times as likely as those not on anticoagulants to have a stroke, and 2.4 times as likely to have a haemorrhage. There was not, however, an increased risk of death.
Keyword: Stroke
Link ID: 24668 - Posted: 02.16.2018
By Ashley Yeager Wandering through a maze with striped gray walls, a mouse searches for turns that will take it to a thirst-quenching reward. Although the maze seems real to the mouse, it is, in fact, a virtual world. Virtual reality (VR) has become a valuable tool to study brains and behaviors because researchers can precisely control sensory cues, correlating nerve-cell activity with specific actions. “It allows experiments that are not possible using real-world approaches,” neurobiologist Christopher Harvey of Harvard Medical School and colleagues wrote in 2016 in a commentary in Nature (533:324–25). Studies of navigation are perfect examples. Extraneous sounds, smells, tastes, and textures, along with internal information about balance and spatial orientation, combine with visual cues to help a mouse move through a maze. In a virtual environment, researchers can add or remove any of these sensory inputs to see how each affects nerve-cell firing and the neural patterns that underlie exploration and other behaviors. But there’s a catch. Many VR setups severely restrict how animals move, which can change nerve cells’ responses to sensory cues. As a result, some researchers have begun to build experimental setups that allow animals to move more freely in their virtual environments, while others have starting using robots to aid animals in navigation or to simulate interactions with others of their kind. Here, The Scientist explores recent efforts in both arenas, which aim to develop a more realistic sense of how the brain interprets reality. © 1986-2018 The Scientist
Keyword: Learning & Memory
Link ID: 24667 - Posted: 02.16.2018
Aimee Cunningham Knocking back an enzyme swept mouse brains clean of protein globs that are a sign of Alzheimer’s disease. Reducing the enzyme is known to keep these nerve-damaging plaques from forming. But the disappearance of existing plaques was unexpected, researchers report online February 14 in the Journal of Experimental Medicine. The brains of mice engineered to develop Alzheimer’s disease were riddled with these plaques, clumps of amyloid-beta protein fragments, by the time the animals were 10 months old. But the brains of 10-month-old Alzheimer’s mice that had a severely reduced amount of an enzyme called BACE1 were essentially clear of new and old plaques. Studies rarely demonstrate the removal of existing plaques, says neuroscientist John Cirrito of Washington University in St. Louis who was not involved in the study. “It suggests there is something special about BACE1,” he says, but exactly what that might be remains unclear. One theory to how Alzheimer’s develops is called the amyloid cascade hypothesis. Accumulation of globs of A-beta protein bits, the idea goes, drives the nerve cell loss and dementia seen in the disease, which an estimated 5.5 million Americans had in 2017. If the theory is right, then targeting the BACE1 enzyme, which cuts up another protein to make A-beta, may help patients. |© Society for Science & the Public 2000 - 2018.
Keyword: Alzheimers
Link ID: 24666 - Posted: 02.15.2018
By Andy Coghlan Surgical instruments may need to be cleaned more thoroughly after brain operations, following the news that they might be spreading proteins linked to Alzheimer’s disease. There’s no evidence yet that spreading these proteins from one person to another can cause Alzheimer’s disease itself. But a study of eight people suggests that unclean instruments may sometimes lead to a rare and potentially fatal kind of brain bleeding disorder. People who have Alzheimer’s disease typically have plaques of sticky amyloid proteins in their brains, although it remains unclear whether these are a cause or a consequence of the condition. But when amyloid builds up in blood vessels in the brain, it can sometimes make them so brittle that they leak or burst. This condition, called cerebral amyloid angiopathy (CAA), usually doesn’t develop until people reach their sixties or older. But Sebastian Brandner, at University College London, and his team have been investigating the cases of eight people who developed CAA under the age of 60. Scouring their medical records, the team found that all eight of these people had undergone brain surgery during childhood or their teenage years for a variety of reasons. Of the eight people, at least three have already died from strokes, which can be caused by CAA. They died between the ages of 37 and 57. © Copyright New Scientist Ltd.
Keyword: Alzheimers; Prions
Link ID: 24665 - Posted: 02.15.2018
By Matt Warren The anesthesia medication ketamine has shown promise in treating depression, but its exact effects on the brain are unclear. Now, researchers have discovered that the drug changes the firing patterns of cells in a pea-size structure hidden away in the center of the brain. This could explain why ketamine is able to relieve symptoms of depression so quickly—and may provide a fresh target for scientists developing new antidepressants. “It’s a spectacular study,” says Roberto Malinow, a neuroscientist at the University of California, San Diego, who was not involved in the work. “It will make a lot of people think.” In clinical trials, ketamine appears to act much faster than existing antidepressants, improving symptoms within hours rather than weeks. “People have tried really hard to figure out why it’s working so fast, because understanding this could perhaps lead us to the core mechanism of depression,” says Hailan Hu, a neuroscientist at Zhejiang University School of Medicine in Hangzhou, China, and a senior author on the new study. Hu suspected the drug might target a tiny region in the middle of the brain called the lateral habenula, the so-called “anti–reward center.” This region inhibits nearby reward areas, which can be useful in learning; for example, if a monkey pulls a lever expecting a treat but never receives it, the lateral habenula will reduce the activity of reward areas, and the monkey will be less likely to pull the lever in the future. But research over the past decade has suggested that the area may be overactive in depression, dampening down those reward centers too much. © 2018 American Association for the Advancement of Science.
Keyword: Depression; Drug Abuse
Link ID: 24664 - Posted: 02.15.2018
By SHEILA KAPLAN and KEN BELSON The Food and Drug Administration on Wednesday approved a long-awaited blood test to detect concussions in people and more quickly identify those with possible brain injuries. The test, called the Banyan Brain Trauma Indicator, is also expected to reduce the number of people exposed to radiation through CT scans, or computed tomography scans, that detect brain tissue damage or intracranial lesions. If the blood test is adopted widely, it could eliminate the need for CT scans in at least a third of those with suspected brain injuries, the agency predicted. Concussion-related brain damage has become a particularly worrisome public health issue in many sports, especially football, affecting the ranks of professional athletes on down to the young children in Pop Warner leagues. Those concerns have escalated so far that it has led to a decline in children participating in tackle sports. “This is going to change the testing paradigm for suspected cases of concussion,” said Tara Rabin, a spokeswoman for the F.D.A. She noted that the agency had worked closely on the application with the Defense Department, which has wanted a diagnostic tool to evaluate wounded soldiers in combat zones. The Pentagon financed a 2,000-person clinical trial that led to the test’s approval. According to the Centers for Disease Control and Prevention, there were about 2.8 million visits to emergency rooms for traumatic brain injury-related conditions in 2013, the most recent year for which the numbers were available. Of these, nearly 50,000 people died. Most patients with suspected traumatic brain injury are evaluated using a neurological exam, followed by a CT scan. © 2018 The New York Times Company
Keyword: Brain Injury/Concussion
Link ID: 24663 - Posted: 02.15.2018
By Ricki Rusting, Every morning, Avigael Wodinsky sets a timer to keep her 12-year-old son, Naftali, on track while he gets dressed for school. “Otherwise,” she says, “he’ll find 57 other things to do on the way to the bathroom.” Wodinsky says she knew something was different about Naftali from the time he was born, long before his autism diagnosis at 15 months. He lagged behind his twin sister in hitting developmental milestones, and he seemed distant. “When he was an infant and he was feeding, he wouldn’t cry if you took the bottle away from him,” she says. He often sat facing the corner, turning the pages of a picture book over and over again. Although he has above-average intelligence, he did not speak much until he was 4, and even then his speech was often ‘scripted:’ He would repeat phrases and sentences he had heard on television. Naftali’s trouble with maintaining focus became apparent in preschool—and problematic in kindergarten. He would stare out the window or wander around the classroom. “He was doing everything except what he was supposed to be doing,” Wodinsky recalls. At first, his psychiatrist credited these behaviors to his autism and recommended he drink coffee for its mild stimulant effect. The psychiatrist also suggested anxiety drugs. Neither treatment helped. A doctor then prescribed a series of drugs used for attention deficit hyperactivity disorder (ADHD), even though Naftali’s hyperactivity was still considered a part of his autism; those medications also failed or caused intolerable side effects. © 2018 Scientific American
/ By Dinsa Sachan When reporting a rape to police or testifying during a trial, it’s not uncommon for women to face a barrage of intrusive questions: What were you wearing at the time of the assault? Were you intoxicated? Why were you walking home alone at night? For decades, social psychologists have documented links between the ways society perceives women and their bodies — ones that often lead to this line of questioning — and attitudes towards gender violence. But only recently have neuroscientists begun to investigate what sexual objectification actually looks like in the brain. In a study published in the journal Cortex in December, European researchers explored the relationship between empathy — the ability to feel others’ emotions — and sexual objectification. Their findings, based on measuring brain activity in response to viewing a woman being left out of a social activity, suggest that people feel less empathy for women dressed in revealing clothing compared to those dressed more conservatively. To conduct the research, Giorgia Silani, a neuroscientist at the University of Vienna, Austria, along with her colleagues, asked 36 participants — both men and women — to participate in and watch videos of others playing a digital ball-tossing game. The videos featured a model who either wore long pants, a plain top, and light makeup, or a short dress, high heels, and heavy makeup. At different points in the videos, the model was included or excluded from the game. Copyright 2018 Undark
Keyword: Emotions; Brain imaging
Link ID: 24661 - Posted: 02.15.2018
By JOANNA KLEIN FEB. 13, 2018 If Cupid wanted to make two songbirds fall in love, he’d have better luck aiming at their brains. That’s because songbirds, which form lifelong mating pairs, have brain systems perfectly tuned to fit together. While you sort through the messages of admirers, deciding who to make your Valentine, consider finches. Young males in this family of feathered crooners learn the song of their father, perfect it and perform it as adults to attract a lifelong mate. It’s loud, elaborate and precise. With their songs they say “chirp, chirp — my brain is healthy, and my body is strong. That’s something you’re into, right?” A female finch also learns the songs of her father from a young age, but she doesn’t perform. She’s the critic. She analyzes every detail of a potential mate’s song, compares it to her father’s example and decides if this performer is one she’d like to keep around. If she detects a song is too simple or off in any way, she’ll have nothing to do with its performer. She’s very picky, as she should be, because the mate she chooses will help raise their young — till death do they part. Over the past decade, researchers looking into the chickpea-sized brains of finches have discovered that each sex uses what’s called its sound control system to convert sound waves to social messages and then use them to find mates, kind of how humans use vocal sounds to communicate. And while these systems are well-developed and finely tuned in both sexes of songbirds, the wiring is different. “The biggest difference between male and female brains of the same species is found in songbirds,” said Sarah Woolley, a neuroscientist who studies finches at Columbia University’s Zuckerman Institute. Dr. Woolley’s lab has been looking into the acoustic systems of zebra, bengalese and long-tailed finches to see how their brains take in and process sounds — learning, performing and analyzing different parts of them to make sense of songs. © 2018 The New York Times Company
Keyword: Sexual Behavior; Animal Communication
Link ID: 24660 - Posted: 02.14.2018
An all-female freshwater fish species called the Amazon molly that inhabits rivers and creeks along the Texas-Mexico border is living proof that sexual reproduction may be vastly overrated. Scientists said on Monday they have deciphered the genome of the Amazon molly, one of the few vertebrate species to rely upon asexual reproduction, and discovered that it had none of the genetic flaws, such as an accumulation of harmful mutations or a lack of genetic diversity, they had expected. They found that the Amazon molly, named after the fierce female warriors of ancient Greek mythology, boasts a hardy genetic makeup that makes it equally fit, or even more so, than fish using sexual reproduction in which both maternal and paternal genes are passed along to offspring. "The Amazon molly is doing quite well," said biologist Manfred Schartl of the University of Wuerzburg in Germany. "Unexpectedly, we did not find the signs of genomic decay as predicted." The fish reproduces using a strategy in which a female's egg cell develops into a baby without being fertilized by a male's sperm cell. But that does not mean the fish does not need some hanky panky. "The Amazon molly female produces clones of itself by duping a male of a closely related species to mate with her. The asexual mode of reproduction termed gynogenesis requires the female to mate with a male but none of the male's genome is passed to the offspring," said geneticist Wesley Warren of the McDonnell Genome Institute at Washington University in St. Louis. ©2018 CBC/Radio-Canada.
Keyword: Sexual Behavior; Evolution
Link ID: 24659 - Posted: 02.14.2018
Dean Burnett The internet is a weird place. Part of this is due to how things linger rather than disappear, as they tended to do with more “traditional” media. Nowadays, people’s jobs can (rightly or wrongly) be endangered for tweets they wrote years ago. The adage about “today’s news is tomorrow’s fish and chip papers” seems no longer to apply. This is particularly true when a headline or story from years ago can be found by a group or community on a social network that missed it previously, so they share it widely and it ends up in your feeds long after it’s been “forgotten”. It can be a bit confusing for those of us who grew up solely with televised news. It’s like watching the weekend football roundup when it’s suddenly interrupted by a report that the Berlin Wall has come down. Case in point: yesterday I saw several examples of a story from 2015 about how scientists have discovered that cheese triggers the same part of the brain as hard drugs. A lot of people seem to be sharing this again (even me, thinking it was new). You’d assume someone well-versed in neuroscience like myself would easily recognise an old story like this. So why didn’t I? Stories like this are hardly uncommon. You can barely go a month without some study or report describing something supposedly innocuous as having the same effect on the brain, or activating the same brain regions, as drugs of abuse, be it sugar, pornography, religion, sex, Facebook, music, or, apparently, cheese. Give it a week, something else will be cited as stimulating our brains just like the most powerful narcotics. Maybe walking on crunchy leaves or taking your bra off after a long day will be described as the equivalent of inhaling a bin-bag full of cocaine? © 2018 Guardian News and Media Limited
Keyword: Drug Abuse; Attention
Link ID: 24658 - Posted: 02.14.2018
By NEIL GENZLINGER Anne M. Treisman, whose insights into how we perceive the world around us provided some of the core theories for the field of cognitive psychology, died on Friday at her home in Manhattan. She was 82. Her daughter Deborah Treisman said the cause was a stroke after a long illness. Dr. Treisman considered a fundamental question: How does the brain make sense of the bombardment of input it is receiving and focus attention on a particular object or activity? What she came up with is called the feature integration theory of attention, detailed in a much-cited 1980 article written with Garry Gelade in the journal Cognitive Psychology, then refined and elaborated on in later work. “Perhaps Anne’s central insight in the field of visual attention was that she realized that you could see basic features like color, orientation and shape everywhere in the visual field, but that there was a problem in knowing how those colors, orientations, shapes, etc., were ‘bound’ together into objects,” Jeremy M. Wolfe, director of the Visual Attention Lab of Harvard Medical School and Brigham and Women’s Hospital, explained in an email. “Her seminal feature integration theory,” he continued, “proposed that selective attention to an object or location enabled the binding of those features and, thus, enabled object recognition. Much argument has followed, but her formulation of the problem has shaped the field for almost four decades.” Dr. Treisman did not merely theorize about how perception works; she tested her ideas with countless experiments in which subjects were asked, for instance, to pick a particular letter out of a visual field, or to identify black digits and colored letters flashing by. The work showed not only how we perceive, but also how we can sometimes misperceive. © 2018 The New York Times Company
Keyword: Attention; Vision
Link ID: 24657 - Posted: 02.14.2018
By BENEDICT CAREY Decent memory is a matter of livelihood, of independence, most of all of identity. Human memory is the ghost in the neural machine, a widely distributed, continually changing, multidimensional conversation among cells that can reproduce both the capital of Kentucky and the emotional catacombs of that first romance. The news last week that scientists had developed a brain implant that boosts memory — an implantable “cognitive prosthetic,” in the jargon — should be astounding even to the cynical. App developers probably are already plotting yet another brain-exercise product based on the latest science. Screenwriters working on their next amnesia-assassin scripts got some real-life backup for the pitch meeting. The scientists are in discussions to commercialize the technology, and so people in the throes of serious memory loss, and their families, likely feel a sense of hope, thin though it may be. These things take time, and there are still many unknowns. But for those in the worried-well demographic — the 40-is-the-new-30 crowd, and older — reports of a memory breakthrough fall into a different category. What exactly does it mean that scientists are truly beginning to understand the biology of memory well enough to manipulate it? Which reaction is appropriate: the futurist’s, or the curmudgeon’s? The only honest answer at this stage is both. The developers of the new implant, led by scientists at the University of Pennsylvania and Thomas Jefferson University, built on decades of work decoding brain signals, using the most advanced techniques of machine learning. Their implant, in fact, constitutes an array of electrodes embedded deep in the brain that monitor electrical activity and, like a pacemaker, deliver a stimulating pulse only when needed — when the brain is lagging as it tries to store new information. © 2018 The New York Times Company
Keyword: Learning & Memory; Robotics
Link ID: 24656 - Posted: 02.13.2018


.gif)

